Advertisement

BioCryst Pharmaceuticals, Inc. Company Profile

04:01 EDT 18th June 2013 | BioPortfolio

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds that are in late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Additionally, BioCryst has a third product candidate, BCX4208—a next generation PNP inhibitor—in mid-stage trials for the treatment of gout. Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. For more information please visit BioCryst’s Web site at www.biocryst.com.


News Articles [ 92 Associated News Articles listed on BioPortfolio]

BioCryst, Presidio Call Off Proposed Acquisition

NEW YORK (AP) — BioCryst Pharmaceuticals Inc. and Presidio Pharmaceuticals Inc. said Friday that they have mutually agreed to end their agreement for Presidio to be purchased by BioCryst

PropThink: PropThink: BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment

By Jake King In an all-stock merger announced (http://investor.shareholder.com/biocryst/ReleaseDetail.cfm?ReleaseID=714478) Thursday morning, BioCryst Pharmaceuticals (NASDAQ:BCRX) will acquire pr...

FDA has safety concerns over BioCryst's hep C drug

RESEARCH TRIANGLE PARK, N.C. (AP) — Shares of drugmaker BioCryst Pharmaceuticals Inc. plunged Wednesday after the company said it was withdrawing its regulatory application for a hepatitis C drug du...

BioCryst withdraws BCX5191 lND following discussion with FDA

US biotech firm BioCryst Pharmaceuticals (Nasdaq: BCRX) says it is withdrawing its Investigational New Drug (IND) application for the antiviral nucleoside, BCX5191, following a discussion with the US...

BioCryst and Presidio to merge, creating new competitor in HCV arena

USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately held Presidio Pharmaceuticals in an all-stock transaction that values the latter at around $10...

BioCryst Investors Breathe Sight Of Relief, But What's Next?

By EP Vantage:Completing BioCryst's (BCRX) all-share takeover of Presidio Pharmaceuticals was always going to be tricky after the acquiring company's stock lost two-thirds of its value. But the curio...

Biocryst Pharmaceuticals: Company profile

Summary Website: Biocryst Pharmaceuticals Headquarters: North Carolina, USA SEC URL: Biocryst Pharmaceuticals Top BigBiotech ranking*: 45 *Ranking based on reported global biotech sales for year end...

BioCryst Won't Profit From Bird Flu Outbreak in China

DURHAM, NC (TheStreet) -- BioCryst Pharmaceuticals shares are trading higher because another bird flu outbreak has hit China, leading the China State Food and Drug Administration to approve the compa...

Drugs and Medications [0 Results]

None

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.

Please cite this paper as: Hernandez et al. (2011) Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other R...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes. By integrating multiple scientifi...

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory disea...

More Information about "BioCryst Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of BioCryst Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of BioCryst Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about BioCryst Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioCryst Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant BioCryst Pharmaceuticals, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement